Vienna-based Themis Bioscience frontlines vaccine development against emerging diseases
From Switzerland, we depart once again, this time for Vienna. This week, we are visiting…
From Switzerland, we depart once again, this time for Vienna. This week, we are visiting…
These potentially fatal diseases have reached pandemic proportions and are starting to threaten the Western world. Excivion…
A court finally allowed the release of Oxitec's 'friendly' mosquitoes in the Grand Cayman (1…
Cancer Research UK says an old anti-malaria drug could be repurposed as a cancer therapy. In…
Researchers from the Max Planck Institute of Molecular Plant Physiology in Potsdam have altered tobacco…
Paris & Strasbourg (France) researchers have discovered an 'Achilles Heel' for malaria: A specific molecule the…
Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes…
The Nobel Prize for Medicine and Physiology has been jointly awarded to Youyou Tu (the…
Oxitec's self-limiting gene technique, which is designed to exterminate dangerous insects, has a price now:…
Olivier Brandicourt, new CEO of Sanofi since last April, has been interviewed by EuroBusiness Media…
Sanofi extended its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new…
University of Copenhagen released a vaccine candidate against the form of malaria that strikes pregnant…